Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.099 AUD | -1.00% | +4.21% | -10.00% |
May. 06 | IDT Australia Secures Victorian Government Funding for Cancer Medication Production Facility | MT |
Apr. 16 | IDT Australia Signs Master Service Agreement with Sanofi | MT |
Sales 2022 | 12.13M 8.12M | Sales 2023 | 7.03M 4.71M | Capitalization | 23.76M 15.9M |
---|---|---|---|---|---|
Net income 2022 | -1M -669K | Net income 2023 | -8M -5.35M | EV / Sales 2022 | 1.6 x |
Net cash position 2022 | 8.33M 5.58M | Net cash position 2023 | 3.69M 2.47M | EV / Sales 2023 | 2.85 x |
P/E ratio 2022 |
-23
x | P/E ratio 2023 |
-1.87
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.18% |
1 day | -1.00% | ||
1 week | +4.21% | ||
Current month | +4.21% | ||
1 month | +2.06% | ||
3 months | -1.00% | ||
6 months | +16.47% | ||
Current year | -10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Paul McDonald
CEO | Chief Executive Officer | - | 20-12-31 |
Director of Finance/CFO | - | 22-09-27 | |
Kagiaros Chris
HRO | Human Resources Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
CHM | Chairman | 54 | 22-10-09 |
Geoffrey Sam
BRD | Director/Board Member | - | 22-10-09 |
Jane Ryan
BRD | Director/Board Member | 65 | 22-01-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.099 | -1.00% | 169,388 |
24-05-15 | 0.1 | -2.44% | 6,903 |
24-05-14 | 0.1025 | +5.67% | 193,696 |
24-05-13 | 0.097 | +2.11% | 80,455 |
24-05-10 | 0.095 | -2.06% | 38,083 |
Delayed Quote Australian S.E., May 15, 2024 at 11:54 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-10.00% | 23.23M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- IDT Stock